Semaglutide injection
From W8MD weight loss and sleep centers
Semaglutide weekly injections, injection sites, storage, missed dose guidance, safety, results, and affordable GLP-1 weight loss injections at W8MD
| Semaglutide injection
| |
|---|---|
| Trade names | Wegovy, Ozempic |
| Generic name | Semaglutide |
| Drug class | GLP-1 receptor agonist, anti-obesity medication, incretin mimetic, diabetes medication |
| Routes of administration | Subcutaneous injection |
| Uses | Chronic weight management, obesity, overweight with weight-related conditions, type 2 diabetes, selected cardiovascular risk reduction |
| Mechanism of action | Appetite reduction, improved satiety, delayed gastric emptying, glucose-dependent insulin secretion, reduced glucagon secretion |
| Dosing frequency | Once weekly
|
| Related drugs | Wegovy, Ozempic, Rybelsus, Tirzepatide, Zepbound, Mounjaro, GLP-1 weight loss injections |
Semaglutide Injection
Semaglutide injection is a once-weekly subcutaneous injection used in brand-name medications such as Wegovy and Ozempic. Semaglutide is a GLP-1 receptor agonist that helps selected patients with obesity, overweight, type 2 diabetes, and related cardiometabolic risks by reducing appetite, improving satiety, decreasing food noise, slowing gastric emptying, and supporting better blood glucose regulation.
At W8MD Weight Loss, Sleep and MedSpa, eligible patients can be evaluated for semaglutide weight loss, Wegovy for weight loss, Ozempic for weight loss education, and affordable GLP-1 weight loss injections when medically appropriate.
W8MD affordable semaglutide injection program: W8MD offers affordable GLP-1 weight loss injection options, including semaglutide-based treatment when medically appropriate, starting as low as $29.99 per week and up with insurance for qualifying visits, or $59.99 per week and up for self-pay patients when available. Pricing, eligibility, medication access, pharmacy availability, and insurance coverage vary by patient, location, and medical evaluation.
Overview
Semaglutide injection is a prescription injectable medication given under the skin once weekly. It is part of the GLP-1 receptor agonist class and is used in different brand-name products:
- Wegovy - used for chronic weight management and selected cardiovascular risk reduction in patients with obesity or overweight
- Ozempic - used for type 2 diabetes and selected cardiometabolic indications
- Rybelsus - oral semaglutide used for type 2 diabetes, not a weekly injection
Semaglutide injection is not a traditional diet pill. It works through hormone pathways involved in appetite regulation, satiety, food noise, blood glucose, insulin secretion, glucagon suppression, and gastric emptying. It should be used under medical supervision and combined with a structured plan for medical weight loss, nutrition, hydration, activity, sleep optimization, and long-term maintenance.
Important points for patients
Key takeaways
Weekly injection
Most semaglutide injection products are taken once weekly, on the same day each week.
Injection sites
Common sites include the abdomen, thigh, or upper arm, with site rotation to reduce irritation.
Storage matters
Semaglutide injection products require proper storage and protection from heat, freezing, and light.
Medical supervision
W8MD helps with safe use, dose escalation, side effects, nutrition, and long-term maintenance.
How weekly semaglutide injections work
Semaglutide injection is usually taken once weekly. The medication is designed to remain active long enough that daily injections are not needed. Most patients choose one day of the week and inject on that day each week, unless their clinician gives different instructions.
Weekly injections may help because they are:
- Easier to remember than daily injections for many patients
- Convenient for busy schedules
- Helpful for gradual semaglutide dose escalation
- Useful for steady appetite control
- Compatible with structured follow-up visits
- Helpful for long-term chronic weight management
Semaglutide should be used exactly as prescribed. Patients should not increase the dose early, inject more often than directed, combine it with another GLP-1 medication, or restart after a long interruption without medical guidance.
How semaglutide helps with weight loss
Semaglutide activates the GLP-1 receptor. GLP-1 is a natural gut hormone involved in appetite, fullness, digestion, and glucose regulation.
Semaglutide may help patients lose weight by:
- Reducing appetite
- Increasing satiety
- Reducing food noise
- Helping patients feel full sooner
- Reducing cravings
- Reducing portion size
- Slowing gastric emptying
- Supporting glucose-dependent insulin secretion
- Reducing inappropriate glucagon secretion
- Improving ability to follow a nutrition plan
Semaglutide does not replace healthy habits. It works best with protein planning, reduced-calorie nutrition, hydration, physical activity, resistance training, sleep improvement, and long-term maintenance.
Common semaglutide injection brands
| Brand | Active ingredient | Route | Main use | Patient education point |
|---|---|---|---|---|
| Wegovy | Semaglutide | Once-weekly injection | Chronic weight management and selected cardiovascular risk reduction | The brand most directly associated with semaglutide weight loss |
| Ozempic | Semaglutide | Once-weekly injection | Type 2 diabetes | Patients often search for Ozempic for weight loss, but Wegovy is the weight-management brand |
| Rybelsus | Semaglutide | Oral tablet | Type 2 diabetes | Not a weekly injection |
Semaglutide injection sites
Semaglutide is injected under the skin, not into muscle or a vein. Common injection sites include:
- Abdomen
- Thigh
- Upper arm
When using the upper arm, some patients may need another person to help. Patients should rotate injection sites with each dose to reduce irritation, bruising, soreness, and injection-site reactions.
How to rotate injection sites
Site rotation means using a different area each week rather than injecting into the exact same spot repeatedly.
| Week | Example site | Notes |
|---|---|---|
| Week 1 | Abdomen, right side | Avoid the navel area |
| Week 2 | Abdomen, left side | Choose a different spot from week 1 |
| Week 3 | Right thigh | Inject into fatty tissue under the skin |
| Week 4 | Left thigh | Rotate again the next week |
| Week 5 | Upper arm | May require help from another person |
Avoid injecting into skin that is tender, bruised, red, hard, scarred, infected, irritated, or swollen.
Step-by-step patient injection overview
Patients should always follow the official Instructions for Use that come with their specific semaglutide product. General steps usually include:
- Wash hands.
- Check the medication label and expiration date.
- Inspect the medication. Do not use if it appears cloudy, discolored, frozen, or contains particles.
- Choose an approved injection site.
- Rotate away from the previous injection site.
- Clean the skin if instructed.
- Use the pen, vial, or syringe exactly as instructed.
- Do not reuse needles, syringes, or single-use pens.
- Dispose of used needles or injection devices in an FDA-cleared sharps container.
- Record the injection day, dose, and injection site.
Patients should ask the W8MD team, pharmacist, or prescribing clinician for hands-on teaching if they are unsure how to inject.
Storage of semaglutide injections
Proper storage is important for safety and effectiveness. Storage instructions vary by brand and dosage form, so patients should follow the label that comes with their exact medication.
Wegovy storage
Wegovy injection pens are generally stored in the refrigerator before use. They should not be frozen and should be protected from light. According to Wegovy prescribing information, Wegovy injection pens may be kept at room temperature within the labeled limits for a limited period when needed.<ref name="WegovyLabel">Wegovy prescribing information(link). U.S. Food and Drug Administration.2026.</ref>
General Wegovy storage reminders:
- Store in the refrigerator as directed.
- Do not freeze.
- Do not use if frozen.
- Protect from light.
- Keep in the original carton when appropriate.
- Keep out of reach of children and pets.
- Do not use past the expiration date.
Ozempic storage
Ozempic pens are generally stored in the refrigerator before first use. After first use, Ozempic pens may be stored as directed in the refrigerator or at room temperature for the period allowed by the prescribing information. The pen cap should be kept on when not in use to protect from light.<ref name="OzempicLabel">Ozempic prescribing information(link). Novo Nordisk.</ref>
General Ozempic storage reminders:
- Store unopened pens in the refrigerator as directed.
- Do not freeze.
- Do not use if frozen.
- Protect from excessive heat and light.
- Keep the pen cap on when not in use.
- Dispose of the pen after the labeled in-use period, even if medication remains.
If medication has been left out too long, frozen, exposed to heat, or looks abnormal, patients should contact their pharmacist or prescriber before using it.
Traveling with semaglutide injections
Patients traveling with semaglutide should plan ahead.
Helpful travel tips include:
- Keep medication in the original labeled package.
- Use an insulated medication travel case when needed.
- Avoid leaving medication in a hot car.
- Avoid direct sunlight.
- Do not freeze the medication with ice packs touching the pen or vial.
- Carry a sharps container or safe needle disposal plan.
- Bring enough medication for the trip.
- Check airline and destination rules for injectable medications.
Missed dose guidance
Missed-dose instructions differ by semaglutide brand. Patients should follow the instructions for the exact product prescribed.
Missed Wegovy injection
For Wegovy injection, official prescribing information states that if one dose is missed and the next scheduled dose is more than 2 days away, the patient should administer Wegovy as soon as possible. If the next scheduled dose is less than 2 days away, the patient should skip the missed dose and resume on the regular day. If two or more consecutive doses are missed, patients may resume as scheduled or may need to restart dose escalation to reduce gastrointestinal side effects, depending on clinician guidance.<ref name="WegovyLabel" />
Missed Ozempic injection
For Ozempic, official prescribing information states that if a dose is missed, administer it as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and take the next dose on the regularly scheduled day.<ref name="OzempicLabel" />
| Product | Missed-dose timing | General guidance | Safety note |
|---|---|---|---|
| Wegovy | Next scheduled dose more than 2 days away | Take the missed dose as soon as possible | Resume weekly schedule as instructed |
| Wegovy | Next scheduled dose less than 2 days away | Skip the missed dose | Take the next dose on the regular day |
| Ozempic | Within 5 days after missed dose | Take the missed dose as soon as possible | Resume weekly schedule as instructed |
| Ozempic | More than 5 days after missed dose | Skip the missed dose | Take the next dose on the regular day |
| Any semaglutide injection | Missed multiple doses | Contact clinician before restarting | Dose may need adjustment for tolerability |
Patients should not double doses without medical guidance.
Semaglutide dose escalation
Semaglutide is usually started at a low dose and increased gradually to reduce side effects. Dose escalation should be individualized based on response, tolerability, weight loss, blood sugar, side effects, and medical history.
Wegovy injection dose escalation
| Dose | Typical role | Patient education point |
|---|---|---|
| 0.25 mg once weekly | Starting dose | Helps the body adjust |
| 0.5 mg once weekly | Escalation dose | Usually follows the starting dose |
| 1 mg once weekly | Escalation dose | Gradual dose increase |
| 1.7 mg once weekly | Escalation or maintenance option | May be used depending on response and tolerability |
| 2.4 mg once weekly | Standard maintenance dose | Common long-term Wegovy maintenance dose |
| 7.2 mg once weekly | High-dose option | Wegovy HD may be considered for selected adults when appropriate |
See also Semaglutide dose escalation and Wegovy for weight loss.
Ozempic injection dose escalation
Ozempic dosing is designed for type 2 diabetes treatment and follows its own prescribing information. Patients should not use Ozempic for weight loss without medical supervision and should not substitute Ozempic for Wegovy without clinician guidance.
Safety and medical supervision
Semaglutide injections require medical supervision because patient selection, dosing, storage, side effects, drug interactions, and contraindications vary.
W8MD medical supervision can help with:
- Determining whether semaglutide is appropriate
- Reviewing medical history
- Reviewing current medications
- Checking contraindications
- Evaluating BMI
- Documenting weight-related medical conditions
- Managing side effects
- Adjusting dose escalation
- Monitoring blood glucose
- Supporting hydration and nutrition
- Preventing excessive muscle loss
- Coordinating sleep apnea screening
- Planning long-term weight maintenance
Who should not use semaglutide?
Semaglutide is not appropriate for everyone. Patients should discuss risks with a healthcare provider if they have:
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2
- History of pancreatitis
- Gallbladder disease
- Severe gastrointestinal disease
- Kidney disease
- Type 1 diabetes
- Use of insulin or sulfonylurea
- Pregnancy or plans for pregnancy
- Breastfeeding
- Eating disorder history
- Severe dehydration risk
- Prior serious allergic reaction to semaglutide
The prescribing information for semaglutide products includes a boxed warning related to thyroid C-cell tumors observed in animal studies and contraindications for patients with personal or family history of medullary thyroid carcinoma or MEN2.<ref name="WegovyLabel" /><ref name="OzempicLabel" />
Common side effects
Common semaglutide side effects may include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal discomfort
- Gastroesophageal reflux disease
- Burping
- Bloating
- Injection-site reactions
- Fatigue
- Reduced appetite
- Headache in some patients
Side effects often occur during dose escalation and may improve with smaller meals, slower eating, hydration, lower-fat food choices, and dose adjustment under medical supervision.
When to call a doctor
Patients should contact their clinician promptly if they develop:
- Severe or persistent abdominal pain
- Pain radiating to the back
- Persistent vomiting
- Severe diarrhea
- Signs of dehydration
- Yellowing of the skin or eyes
- Severe constipation
- Blood sugar symptoms
- Allergic reaction symptoms
- Swelling of face, lips, tongue, or throat
- Trouble breathing
- A lump in the neck
- Hoarseness or trouble swallowing
- Vision changes in patients with diabetes
For severe allergic reaction, chest pain, trouble breathing, fainting, or emergency symptoms, call 911.
Nutrition while using semaglutide injections
Semaglutide reduces appetite, but nutrition quality remains essential. Since patients may eat less, every meal should provide meaningful nutrition.
W8MD may advise patients to focus on:
- Protein-first meals
- Smaller portions
- Hydration
- Fiber as tolerated
- Non-starchy vegetables
- Lean protein
- Greek yogurt
- Eggs
- Fish
- Poultry
- Protein shake
- Avoiding greasy meals if nausea occurs
- Avoiding sugary drinks
- Electrolytes when appropriate
Muscle preservation during semaglutide weight loss
Weight loss can include both fat loss and lean mass loss. Semaglutide patients should protect muscle through:
- Adequate protein
- Resistance training
- Walking
- Strength exercises
- Hydration
- Sleep quality
- Avoiding excessive calorie restriction
- Medical monitoring
Semaglutide and sleep apnea
Many patients with obesity also have undiagnosed obstructive sleep apnea, which can worsen fatigue, cravings, blood pressure, insulin resistance, and difficulty losing weight. W8MD’s combined focus on medical weight loss and sleep medicine allows patients to address both conditions.
Sleep symptoms to discuss include:
- Snoring
- Daytime sleepiness
- Morning headaches
- Waking up choking or gasping
- Witnessed pauses in breathing
- Fatigue despite sleep
- High blood pressure
- Weight gain or difficulty losing weight
Patients with symptoms may benefit from sleep apnea screening, home sleep study, CPAP, APAP, or BiPAP evaluation.
How W8MD can help
W8MD semaglutide injection program highlights
Affordable access
Semaglutide-based GLP-1 injection options may start as low as $29.99 per week and up with insurance for visits, or $59.99 per week and up for self-pay patients when available.
Injection teaching
W8MD can help patients understand weekly injection schedules, injection sites, rotation, storage, missed doses, and sharps disposal.
Brand and semaglutide options
Patients may discuss Wegovy, Ozempic for weight loss education, or semaglutide-based options depending on preference, insurance coverage, safety, and availability.
Long-term support
W8MD supports nutrition, protein intake, resistance training, side-effect management, sleep apnea screening, and weight maintenance.
W8MD can help eligible patients with:
- Semaglutide injection
- Semaglutide weight loss
- Wegovy for weight loss
- Ozempic for weight loss education
- Semaglutide side effects
- Semaglutide dose escalation
- Semaglutide maintenance therapy
- Semaglutide and appetite
- Semaglutide and cardiovascular risk
- GLP-1 weight loss injections
- Injection-site education
- Missed-dose education
- Storage and travel education
- Side-effect management
- Nutrition and protein planning
- Meal replacements
- Low-carbohydrate diet counseling
- Exercise counseling
- Resistance training
- Sleep apnea screening
- Home sleep study
- Long-term weight maintenance
W8MD results and success themes
What successful patients often notice
Individual results vary, but patients in physician-supervised GLP-1 weight-loss programs often report several common success themes when medication is combined with nutrition, protein planning, movement, sleep care, and follow-up.
These are general success themes and not a guarantee of results. Outcomes depend on medical history, medication response, dose, adherence, nutrition, activity, sleep, side effects, medication access, and long-term follow-up.
Affordable semaglutide injection pricing at W8MD
Affordable GLP-1 weight loss injections
W8MD helps eligible patients get started with physician-supervised semaglutide-based injections when medically appropriate.
- Semaglutide-based injection options starting as low as $29.99 per week and up with insurance for qualifying visits.
- Self-pay semaglutide-based options starting from $59.99 per week and up when available and medically appropriate.
- Most insurances accepted for qualifying medical visits.
- Brand-name options may include Wegovy or Ozempic education depending on indication, coverage, and clinical appropriateness.
- Pricing, insurance coverage, medication availability, pharmacy access, and eligibility vary by patient, location, medication, and medical evaluation.
Semaglutide injections in New York City, New Jersey, Connecticut, Pennsylvania, and Delaware
Patients searching for semaglutide injections near me, semaglutide NYC, semaglutide Brooklyn, semaglutide New Jersey, semaglutide Connecticut, semaglutide Philadelphia, semaglutide Pennsylvania, or semaglutide Delaware often want a medical practice that can evaluate them safely and help with medication access.
W8MD serves patients in and around:
Services and medication options may vary by location, state rules, insurance plan, pharmacy availability, and clinical evaluation.
Avoid unsafe online semaglutide products
Patients should avoid unapproved online “research” peptides, counterfeit Wegovy, counterfeit Ozempic, counterfeit semaglutide, or products marketed without legitimate medical supervision. The FDA has warned about concerns with unapproved GLP-1 drugs used for weight loss, including fraudulent compounded semaglutide and tirzepatide products with false labeling.<ref name="FDAUnapprovedGLP1">FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss(link). U.S. Food and Drug Administration.2026-06-15.</ref>
Frequently asked questions
Is semaglutide injection the same as Wegovy?
Semaglutide is the active ingredient. Wegovy is the brand-name semaglutide product used for chronic weight management and selected cardiovascular risk reduction.
Is semaglutide injection the same as Ozempic?
Ozempic also contains semaglutide, but it is used for type 2 diabetes. Patients often search for Ozempic for weight loss, but Wegovy is the semaglutide brand used for chronic weight management.
How often do I take semaglutide injections?
Most semaglutide injection products such as Wegovy and Ozempic are injected once weekly, on the same day each week, unless the prescriber gives different instructions.
Where do I inject semaglutide?
Common injection sites include the abdomen, thigh, or upper arm. Patients should rotate injection sites and avoid irritated, bruised, infected, or scarred skin.
What if I miss a semaglutide dose?
Missed-dose instructions depend on the exact product. Wegovy and Ozempic have different missed-dose instructions. Patients should follow the label for their prescribed medication and ask the prescriber if unsure.<ref name="WegovyLabel" /><ref name="OzempicLabel" />
Does semaglutide need refrigeration?
Semaglutide injection products generally require refrigeration before use and protection from freezing, heat, and light. Exact storage instructions vary between Wegovy, Ozempic, and other semaglutide products.<ref name="WegovyLabel" /><ref name="OzempicLabel" />
Can W8MD help me learn how to inject?
Yes. W8MD can help patients understand weekly injection schedules, injection sites, storage, missed-dose instructions, side effects, and safe use.
How much do semaglutide injections cost at W8MD?
W8MD semaglutide-based injection options may start as low as $29.99 per week and up with insurance for qualifying visits, or $59.99 per week and up for self-pay patients when available and medically appropriate. Pricing and eligibility vary.
Book a semaglutide injection appointment
Request an appointment with W8MD
W8MD offers physician-supervised medical weight loss, semaglutide injection, Wegovy for weight loss, Ozempic for weight loss education, GLP-1 weight loss injections, nutrition support, sleep medicine, and long-term maintenance care in Brooklyn, NY and Philadelphia, PA.
Brooklyn, NY Office
Phone: 718-946-5500
For patients searching for semaglutide injections Brooklyn, semaglutide NYC, Wegovy NYC, Ozempic NYC, GLP-1 weight loss shots NYC, semaglutide New Jersey, or semaglutide Connecticut.
Philadelphia, PA Office
Phone: 215-676-2334
For patients searching for semaglutide injections Philadelphia, Wegovy Philadelphia, Ozempic Philadelphia, semaglutide Pennsylvania, semaglutide Delaware, or GLP-1 shots Philadelphia.
Important: Please do not submit sensitive medical information, Social Security numbers, insurance ID numbers, or urgent medical concerns through online appointment request forms. If this is a medical emergency, call 911.
Related W8MD and GLP-1 pages
- GLP-1 weight loss injections
- Semaglutide weight loss
- Semaglutide injection
- Semaglutide side effects
- Semaglutide dose escalation
- Semaglutide maintenance therapy
- Semaglutide and appetite
- Semaglutide and cardiovascular risk
- Wegovy for weight loss
- Wegovy pill
- Wegovy HD
- Ozempic for weight loss
- Rybelsus
- Tirzepatide weight loss
- Tirzepatide injection
- Zepbound for weight loss
- Mounjaro for weight loss
- Food noise
- Satiety
- Appetite regulation
- Gastric emptying
- Chronic weight management
- Sleep apnea screening
- Medical weight loss
- Obesity medicine
Relevant WikiMD links
- Semaglutide on WikiMD
- Wegovy on WikiMD
- Ozempic on WikiMD
- Rybelsus on WikiMD
- GLP-1 receptor agonist on WikiMD
- Obesity on WikiMD
- Weight loss on WikiMD
- Sleep apnea on WikiMD
External links
- FDA Wegovy prescribing information
- Wegovy prescribing information from Novo Nordisk
- Ozempic prescribing information from Novo Nordisk
- FDA Ozempic prescribing information
- FDA - Wegovy approval for cardiovascular risk reduction
- FDA concerns with unapproved GLP-1 drugs used for weight loss
- Official Wegovy patient website
- Official Ozempic patient website
- W8MD Brooklyn appointment request
- W8MD Philadelphia appointment request